Global Live Attenuated Vaccines Market Research Report 2021

弱毒生ワクチンの世界市場2021

◆タイトル:Global Live Attenuated Vaccines Market Research Report 2021
◆商品コード:QYR60911857
◆調査・発行会社:QYResearch
◆発行日:2016年8月16日
◆ページ数:105
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD3,770 ⇒換算¥426,010見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

※当調査レポートでは、弱毒生ワクチンの世界市場について調査・分析し、市場概観、市場動向、弱毒生ワクチンの世界市場規模、市場予測、地域別市場規模(日本市場、中国市場、米国市場、欧州市場など)、種類別市場分析、用途別市場分析、主要なメーカー分析(企業概要、主な製品概要、生産・販売動向、連絡先など)、市場シェア分析などを含め、以下の構成でお届けいたします。

・弱毒生ワクチンの世界市場:市場概要
・弱毒生ワクチンの世界市場:市場動向
・弱毒生ワクチンの世界市場:市場規模、市場規模予測
・弱毒生ワクチンの地域別市場規模(日本市場、中国市場、アメリカ市場、ヨーロッパ市場など)
・弱毒生ワクチンの世界市場:種類別市場分析
・弱毒生ワクチンの世界市場:用途別市場分析
・弱毒生ワクチンの企業間競争状況
・弱毒生ワクチンの主要なメーカー分析(企業情報、主な製品概要、生産・販売動向、連絡先など)
・弱毒生ワクチンの世界市場:産業政策動向分析
・弱毒生ワクチンの世界市場:市場シェア分析
・弱毒生ワクチンの世界市場:結論
...

Notes:Sales, means the sales volume of Live Attenuated Vaccines
Revenue, means the sales value of Live Attenuated Vaccines

This report studies Live Attenuated Vaccines in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering
Astellas Pharma Inc
CSL Limited
Emergent BioSolutions, Inc
GlaxoSmithKline
Johnson & Johnson
MedImmune, LLC
Merck & Co
Pfizer
Sanofi Pasteur
Serum Institute
India Pvt. Ltd. (India)
Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Live Attenuated Vaccines in these regions, from 2011 to 2021 (forecast), like
North America
China
Europe
Japan
India
Southeast Asia
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Pneumococcal
Influenza
HPV
Hepatitis
Rotavirus
DTP
Polio
MMR
Split by application, this report focuses on sales, market share and growth rate of Live Attenuated Vaccines in each application, can be divided into
Pediatric
Adult
Application 3

【レポートの目次】

Table of Contents

Global Live Attenuated Vaccines Market Research Report 2021
1 Live Attenuated Vaccines Overview
1.1 Product Overview and Scope of Live Attenuated Vaccines
1.2 Live Attenuated Vaccines Segment by Types
1.2.1 Global Sales Market Share of Live Attenuated Vaccines by Type in 2015
1.2.2 Pneumococcal
1.2.3 Influenza
1.2.4 HPV
1.2.5 Hepatitis
1.2.6 Rotavirus
1.2.7 DTP
1.2.8 Polio
1.2.9 MMR
1.3 Live Attenuated Vaccines Segment by Applications
1.3.1 Pediatric
1.3.2 Adult
1.3.3 Application 3
1.4 Live Attenuated Vaccines Market by Regions
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Live Attenuated Vaccines (2011-2021)
1.5.1 Global Live Attenuated Vaccines Sales and Revenue (2011-2021)
1.5.2 Global Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
1.5.3 Global Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)

2 Global Live Attenuated Vaccines Market Competition by Manufacturers
2.1 Global Live Attenuated Vaccines Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Live Attenuated Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Live Attenuated Vaccines Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
2.4.1 Expansions
2.4.2 New Product Launches
2.4.3 Acquisitions
2.4.4 Other Developments

3 Global Live Attenuated Vaccines Analysis by Region
3.1 Global Live Attenuated Vaccines Sales, Revenue and Market Share by Region (2011-2021)
3.1.1 Global Live Attenuated Vaccines Sales Market Share by Region (2011-2021)
3.1.2 Global Live Attenuated Vaccines Revenue Market Share by Region (2011-2021)
3.2 North America
3.2.1 North America Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
3.2.2 North America Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
3.3.1 Europe Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
3.3.2 Europe Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
3.4 China
3.4.1 China Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
3.4.2 China Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
3.5.1 Japan Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
3.5.2 Japan Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
3.6 India
3.6.1 India Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
3.6.2 India Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
3.7.1 Southeast Asia Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
3.7.2 Southeast Asia Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)

4 Global Live Attenuated Vaccines Analysis by Type
4.1 Global Live Attenuated Vaccines Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
4.1.1 Global Live Attenuated Vaccines Sales and Market Share by Type (2011-2021)
4.1.2 Global Live Attenuated Vaccines Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Pneumococcal Sales, Revenue, Price and Growth (2011-2021)
4.3 Influenza Sales, Revenue, Price and Growth (2011-2021)
4.4 HPV Sales, Revenue, Price and Growth (2011-2021)
4.5 Hepatitis Sales, Revenue, Price and Growth (2011-2021)
4.6 Rotavirus Sales, Revenue, Price and Growth (2011-2021)
4.7 DTP Sales, Revenue, Price and Growth (2011-2021)
4.8 Polio Sales, Revenue, Price and Growth (2011-2021)
4.9 MMR Sales, Revenue, Price and Growth (2011-2021)

5 Global Live Attenuated Vaccines Market Analysis by Application
5.1 Global Live Attenuated Vaccines Sales and Market Share by Application (2011-2021)
5.2 Major Regions Live Attenuated Vaccines Sales by Application in 2015 and 2016
5.2.1 North America Live Attenuated Vaccines Sales by Application
5.2.2 Europe Live Attenuated Vaccines Sales by Application
5.2.3 China Live Attenuated Vaccines Sales by Application
5.2.4 Japan Live Attenuated Vaccines Sales by Application
5.2.5 India Live Attenuated Vaccines Sales by Application
5.2.6 Southeast Asia Live Attenuated Vaccines Sales by Application

6 Global Live Attenuated Vaccines Manufacturers Analysis
6.1 Astellas Pharma Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Live Attenuated Vaccines Product Overview
6.1.2.1 Pneumococcal
6.1.2.2 Influenza
6.1.2.3 HPV
6.1.3 Live Attenuated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
6.2 CSL Limited
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Live Attenuated Vaccines Product Overview
6.2.2.1 Pneumococcal
6.2.2.2 Influenza
6.2.2.3 HPV
6.2.3 Live Attenuated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
6.3 Emergent BioSolutions, Inc
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Live Attenuated Vaccines Product Overview
6.3.2.1 Pneumococcal
6.3.2.2 Influenza
6.3.2.3 HPV
6.3.3 Live Attenuated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
6.4 GlaxoSmithKline
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Live Attenuated Vaccines Product Overview
6.4.2.1 Pneumococcal
6.4.2.2 Influenza
6.4.3 Live Attenuated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
6.5 Johnson & Johnson
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Live Attenuated Vaccines Product Overview
6.5.2.1 Pneumococcal
6.5.2.2 Influenza
6.5.3 Live Attenuated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
6.6 MedImmune, LLC
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Live Attenuated Vaccines Product Overview
6.6.2.1 Pneumococcal
6.6.2.2 Influenza
6.6.3 Live Attenuated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
6.7 Merck & Co
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Live Attenuated Vaccines Product Overview
6.7.2.1 Pneumococcal
6.7.2.2 Influenza
6.7.3 Live Attenuated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
6.8 Pfizer
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Live Attenuated Vaccines Product Overview
6.8.2.1 Pneumococcal
6.8.2.2 Influenza
6.8.3 Live Attenuated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
6.9 Sanofi Pasteur
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Live Attenuated Vaccines Product Overview
6.9.2.1 Pneumococcal
6.9.2.2 Influenza
6.9.3 Live Attenuated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
6.10 Serum Institute
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Live Attenuated Vaccines Product Overview
6.10.2.1 Pneumococcal
6.10.2.2 Influenza
6.10.3 Live Attenuated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
6.11 India Pvt. Ltd. (India)

7 Industry Policy Analysis

8 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Live Attenuated Vaccines
Figure Global Sales Market Share of Live Attenuated Vaccines by Type in 2015
Table Live Attenuated Vaccines Product Type of by Manufacturers
Table Live Attenuated Vaccines Sales Market Share by Application in 2015 and 2016
Figure North America Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure China Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure India Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Table Global Live Attenuated Vaccines Sales and Revenue (2011-2021)
Figure Global Live Attenuated Vaccines Sales and Growth Rate (2011-2021)
Figure Global Live Attenuated Vaccines Revenue and Growth Rate (2011-2021)
Table Global Live Attenuated Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Global Live Attenuated Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Live Attenuated Vaccines Sales Share by Manufacturers
Figure 2016 Live Attenuated Vaccines Sales Share by Manufacturers
Table Global Live Attenuated Vaccines Revenue by Manufacturers (2015 and 2016)
Table Global Live Attenuated Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Live Attenuated Vaccines Revenue Share by Manufacturers
Table 2016 Global Live Attenuated Vaccines Revenue Share by Manufacturers
Table Manufacturers Live Attenuated Vaccines Manufacturing Base Distribution and Product Type
Table Global Live Attenuated Vaccines Sales Market by Region (2011-2021)
Figure Global Live Attenuated Vaccines Sales Market by Region (2011-2021)
Figure Global Live Attenuated Vaccines Sales Market Share by Region (2011-2021)
Table Global Live Attenuated Vaccines Revenue Market by Region (2011-2021)
Table Global Live Attenuated Vaccines Revenue Market Share by Region (2011-2021)
Table North America Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure North America Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Europe Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure Europe Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table China Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure China Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Japan Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure Japan Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table India Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure India Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Live Attenuated Vaccines Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Live Attenuated Vaccines Sales, Revenue and Growth Rate (2011-2021)
Table Global Live Attenuated Vaccines Sales by Type (2011-2021)
Table Global Live Attenuated Vaccines Sales Share by Type (2011-2021)
Figure Sales Market Share of Live Attenuated Vaccines by Type (2011-2021)
Figure Global Live Attenuated Vaccines Sales Growth Rate by Type (2011-2021)
Table Global Live Attenuated Vaccines Revenue by Type (2011-2021)
Table Global Live Attenuated Vaccines Revenue Share by Type (2011-2021)
Figure Global Live Attenuated Vaccines Revenue Growth Rate by Type (2011-2021)
Figure Pneumococcal Sales, Revenue and Growth (2011-2021)
Figure Pneumococcal Price Trend (2011-2021)
Figure Influenza Sales, Revenue and Growth (2011-2021)
Figure Influenza Price Trend (2011-2021)
Figure HPV Sales, Revenue and Growth (2011-2021)
Figure HPV Price Trend (2011-2021)
Figure Hepatitis Sales, Revenue and Growth (2011-2021)
Figure Hepatitis Price Trend (2011-2021)
Figure Rotavirus Sales, Revenue and Growth (2011-2021)
Figure Rotavirus Price Trend (2011-2021)
Figure DTP Sales, Revenue and Growth (2011-2021)
Figure DTP Price Trend (2011-2021)
Figure Polio Sales, Revenue and Growth (2011-2021)
Figure Polio Price Trend (2011-2021)
Figure MMR Sales, Revenue and Growth (2011-2021)
Figure MMR Price Trend (2011-2021)
Table Global Live Attenuated Vaccines Sales by Application (2011-2021)
Table Global Live Attenuated Vaccines Sales Market Share by Application (2011-2021)
Figure Global Live Attenuated Vaccines Sales Market Share by Application in 2015
Figure Global Live Attenuated Vaccines Sales Market Share by Application in 2021
Table North America Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table Europe Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table China Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table Japan Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table India Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table Southeast Asia Live Attenuated Vaccines Sales by Application (2015 and 2016)
Table Global Live Attenuated Vaccines Sales Growth Rate by Application (2011-2021)
Figure Global Live Attenuated Vaccines Sales Growth Rate by Application (2011-2021)
Table Astellas Pharma Inc Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
Table CSL Limited Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
Table Emergent BioSolutions, Inc Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table MedImmune, LLC Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
Table Merck & Co Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Sanofi Pasteur Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
Table Serum Institute Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
Table India Pvt. Ltd. (India) Basic Information List
Table Live Attenuated Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[弱毒生ワクチンの世界市場2021] (Global Live Attenuated Vaccines Market Research Report 2021 / QYR60911857)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆